Back to jobs
The Director, is responsible for providing strategic vision, expertise, leadership, and direction to the TA HOER evidence generation team
The Director guides the team responsible for developing the strategic, long-term and integrated Evidence Generation Plans (EGPs) for key products. The team ensures that the evidence is generated based on relevant research questions that are aligned with NNI business priorities. These plans are the drivers for all evidence generation activities across NNI
The Director is responsible for engaging with the Field Medical Affairs and commercial field teams to ensure that EGPs outline evidence that is user friendly, relevant, high quality and communicated during customer conversations
To support these activities, the incumbent is responsible for owning the evidence generation planning process, interfacing with key high-level leaders to drive the process, ensure alignment of commercial and medical to deliver an integrated and impactful evidence generation plan for all key products
Assures that U.S. strategic insights and inputs are provided to shape Global project teams through the Integrated Evidence Planning (IEP) process
Establishes, oversees implementation, and monitors adherence to administrative policies and procedures including those guiding evidence planning
Responsible for evidence generation annual budget, assures evidence generation investments (research, tools, models, publications, field liaisons) are planned and mapped to driving attainment of goals and priorities
Ensures commercial alignment of HEOR research and initiatives with brands, public affairs, market access and medical strategies. Ensures strategic alignment of health economics function with pricing, contracting and marketing to ensure that pricing decisions and brand strategies reflect a good understanding of the need to demonstrate value to customers
Oversees health economics activities to the planning for analyses and cost models that demonstrate the cost-effectiveness and overall value of the brands, and overall product portfolio to specific accounts and customer channels. Helps to ensure health economics perspectives are incorporated in local and global clinical study designs, and in the company’s health policy initiatives
Director, Rare Disease Health Economics and Outcomes Research
Plainsboro, NJPosted 1 weeks ago